Jay Chieh Tung
age ~34
from Temple City, CA
- Also known as:
-
- Jay C Tung
Jay Tung Phones & Addresses
- Temple City, CA
- South San Francisco, CA
- Daly City, CA
- San Diego, CA
- La Jolla, CA
Medicine Doctors
Jay Tung
view sourceSpecialties:
Rheumatology
Work:
Barton Urgent Care & Family Practice
155 Hwy 50 STE 100, Stateline, NV 89449
775 589-8960 (phone), 775 588-7040 (fax)
155 Hwy 50 STE 100, Stateline, NV 89449
775 589-8960 (phone), 775 588-7040 (fax)
Languages:
English
Spanish
Spanish
Description:
Dr. Tung works in Stateline, NV and specializes in Rheumatology. Dr. Tung is affiliated with Barton Memorial Hospital.
Name / Title
Company / Classification
Phones & Addresses
President
BMM TECH INC
6375 Sattes Dr, Rancho Palos Verdes, CA 90275
3820 Del Amo Blvd, Torrance, CA 90503
3820 Del Amo Blvd, Torrance, CA 90503
Us Patents
-
Compounds For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis
view source -
US Patent:6476263, Nov 5, 2002
-
Filed:Apr 3, 2001
-
Appl. No.:09/826412
-
Inventors:Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Jon K. Reel - Carmel IN
Warren J. Porter - Indianapolis IN
Jeffrey S. Nissen - Indianapolis IN
Thomas E. Mabry - Indianapolis IN
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Beverly K. Folmer - Newark DE
James J. Droste - Indianapolis IN
Thomas C. Britton - Carmel IN
James E. Audia - Indianapolis IN -
Assignee:Elan Pharmaceuticals, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN -
International Classification:C07C23300
-
US Classification:564152, 564153, 564159, 564160, 564161, 564 41, 560 41, 562450
-
Abstract:Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis.
-
Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source -
US Patent:6541466, Apr 1, 2003
-
Filed:Jul 27, 2001
-
Appl. No.:09/915362
-
Inventors:Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN -
Assignee:Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN -
International Classification:A61K 3155
-
US Classification:51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
-
Abstract:Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.
-
Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source -
US Patent:6544978, Apr 8, 2003
-
Filed:Jul 27, 2001
-
Appl. No.:09/915480
-
Inventors:Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Bloomington IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN -
Assignee:Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN -
International Classification:A61K 3155
-
US Classification:51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
-
Abstract:Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.
-
Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source -
US Patent:6559141, May 6, 2003
-
Filed:Jul 27, 2001
-
Appl. No.:09/915564
-
Inventors:Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN -
Assignee:Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN -
International Classification:A61K 3155
-
US Classification:51421106, 51421107, 51421204, 51421206, 51421207, 51421208, 540488, 540521, 540522, 540523, 540524, 540527
-
Abstract:Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.
-
Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source -
US Patent:6579867, Jun 17, 2003
-
Filed:Jul 27, 2001
-
Appl. No.:09/915379
-
Inventors:Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN -
Assignee:Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN -
International Classification:A61K 3155
-
US Classification:51421106, 51421107, 51421204, 51421206, 51421207, 51421208
-
Abstract:Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.
-
-Secretase Enzyme Compositions And Methods
view source -
US Patent:6627739, Sep 30, 2003
-
Filed:Nov 28, 2000
-
Appl. No.:09/724566
-
Inventors:John P. Anderson - San Francisco CA
Guriqbal Basi - Palo Alto CA
Minh Tam Doan - Hayward CA
Normand Frigon - Milbrae CA
Varghese John - San Francisco CA
Michael Power - Fremont CA
Sukanto Sinha - San Francisco CA
Gwen Tatsuno - Oakland CA
Jay Tung - Belmont CA
Shuwen Wang - Hersey PA
Lisa McConlogue - Burlingame CA -
Assignee:Elan Pharmaceuticals, Inc. - South San Francisco CA
-
International Classification:C07K 1640
-
US Classification:5303879, 5303881, 53038826, 5303891, 5303892
-
Abstract:Disclosed are various forms of an active, isolated -secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimers disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (-APPwt and -APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate -secretase. Inhibitors of -secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimers disease.
-
Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source -
US Patent:6632811, Oct 14, 2003
-
Filed:Jul 27, 2001
-
Appl. No.:09/915342
-
Inventors:Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Bloomington IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN -
Assignee:Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN -
International Classification:A61K 3155
-
US Classification:514220, 514221
-
Abstract:Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.
-
Cycloalkyl, Lactam, Lactone And Related Compounds, Pharmaceutical Compositions Comprising Same, And Methods For Inhibiting -Amyloid Peptide Release And/Or Its Synthesis By Use Of Such Compounds
view source -
US Patent:6635632, Oct 21, 2003
-
Filed:Dec 22, 1997
-
Appl. No.:08/996422
-
Inventors:Jing Wu - San Mateo CA
Jay S. Tung - Belmont CA
Eugene D. Thorsett - Moss Beach CA
Michael A. Pleiss - Sunnyvale CA
Jeffrey S. Nissen - Indianapolis IN
R. Jeffrey Neitz - San Francisco CA
Lee H. Latimer - Oakland CA
Varghese John - San Francisco CA
Stephen Freedman - Walnut Creek CA
Thomas C. Britton - Carmel IN
James A. Audia - Indianapolis IN
Jon K. Reel - Carmel IN
Thomas E. Mabry - Indianapolis IN
Bruce A. Dressman - Indianapolis IN
Cynthia L. Cwi - Indianapolis IN
James J. Droste - Indianapolis IN
Steven S. Henry - New Palestine IN
Stacey L. McDaniel - Indianapolis IN
William Leonard Scott - Indianapolis IN
Russell D. Stucky - Indianapolis IN
Warren J. Porter - Indianapolis IN -
Assignee:Athena Neurosciences, Inc. - South San Francisco CA
Eli Lilly Company - Indianapolis IN -
International Classification:A61K 3155
-
US Classification:51421203, 51421204, 51421207, 51421208
-
Abstract:Disclosed are compounds which inhibit -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimers disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits -amyloid peptide release and/or its synthesis as well as methods for treating Alzheimers disease both prophylactically and therapeutically with such pharmaceutical compositions.
News
Tapping UCSF Invention, Roche and Versant Dive Into Myelin Repair
view source- Jonahs done a great job, said Jay Tung, chief research officer of the Myelin Repair Foundation in Saratoga, CA, which has worked with Chan in the past. We are ecstatic about pharma, academics, startups, anyone moving the field forward. This is exactly what we want to see.
- Date: Jun 23, 2014
- Category: Health
- Source: Google
Youtube
Jay Tung
view source
Jay Tung
view source
Jay Tung
view source
Jay Tung
view source
Jay Tung
view source
Jay Tung
view source
Jay Tung
view source
Jay Tung
view sourceMyspace
Googleplus
Jay Tung
Work:
Watercolour Gourmet Bakery & Cafe - Manager (2012)
Phyto Wellness Solutions (2011-2012)
Phyto Wellness Solutions (2011-2012)
Jay Tung
Jay Tung
Jay Tung
Jay Tung
Jay Tung
Jay Tung
Jay Tung
Flickr
Get Report for Jay Chieh Tung from Temple City, CA, age ~34